NO20031162D0 - 3-(heteroarylacetamido)-2-okso-azetidin-1-sulfonsyre- derivater som antibakterielle midler - Google Patents

3-(heteroarylacetamido)-2-okso-azetidin-1-sulfonsyre- derivater som antibakterielle midler

Info

Publication number
NO20031162D0
NO20031162D0 NO20031162A NO20031162A NO20031162D0 NO 20031162 D0 NO20031162 D0 NO 20031162D0 NO 20031162 A NO20031162 A NO 20031162A NO 20031162 A NO20031162 A NO 20031162A NO 20031162 D0 NO20031162 D0 NO 20031162D0
Authority
NO
Norway
Prior art keywords
azetidine
oxo
heteroarylacetamido
sulfonic acid
acid derivatives
Prior art date
Application number
NO20031162A
Other languages
English (en)
Other versions
NO324946B1 (no
NO20031162L (no
Inventor
Ronald George Micetich
Samarendra Nath Maiti
Charles Fiakpui
George Thomas
Andhe V Narender Reddy
Sameeh M Salama
Rajeshwar Singh
Original Assignee
Pantherix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantherix Ltd filed Critical Pantherix Ltd
Publication of NO20031162D0 publication Critical patent/NO20031162D0/no
Publication of NO20031162L publication Critical patent/NO20031162L/no
Publication of NO324946B1 publication Critical patent/NO324946B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20031162A 2000-09-14 2003-03-13 3-(heteroarylacetamido)-2-okso-azetidin-1-sulfonsyre-derivater som antibakterielle midler, samt fremstilling og anvendelse derav og farmasoytisk preparat NO324946B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23261700P 2000-09-14 2000-09-14
PCT/IB2001/002115 WO2002022613A1 (en) 2000-09-14 2001-09-14 3-(heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents

Publications (3)

Publication Number Publication Date
NO20031162D0 true NO20031162D0 (no) 2003-03-13
NO20031162L NO20031162L (no) 2003-03-13
NO324946B1 NO324946B1 (no) 2008-01-07

Family

ID=22873854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031162A NO324946B1 (no) 2000-09-14 2003-03-13 3-(heteroarylacetamido)-2-okso-azetidin-1-sulfonsyre-derivater som antibakterielle midler, samt fremstilling og anvendelse derav og farmasoytisk preparat

Country Status (22)

Country Link
US (1) US6916803B2 (no)
EP (1) EP1322648B1 (no)
JP (1) JP2004509122A (no)
KR (1) KR100854810B1 (no)
CN (1) CN1189469C (no)
AT (1) ATE298750T1 (no)
AU (2) AU2002212614B2 (no)
BR (1) BR0113861A (no)
CA (1) CA2422375C (no)
CZ (1) CZ304586B6 (no)
DE (1) DE60111757T2 (no)
DK (1) DK1322648T3 (no)
ES (1) ES2244666T3 (no)
HU (1) HUP0301025A3 (no)
IL (2) IL154593A0 (no)
NO (1) NO324946B1 (no)
NZ (1) NZ524292A (no)
PL (1) PL218196B1 (no)
PT (1) PT1322648E (no)
SK (1) SK2462003A3 (no)
WO (1) WO2002022613A1 (no)
ZA (1) ZA200302085B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2012233003B2 (en) * 2005-12-07 2014-12-18 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
WO2007065288A2 (en) * 2005-12-07 2007-06-14 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
EP2124942B1 (en) * 2007-03-23 2016-04-27 Basilea Pharmaceutica AG Combination medicaments for treating bacterial infections
US20110046101A1 (en) * 2008-03-17 2011-02-24 Dmitrienko Gary I Bate-lactamase inhibitors
CA2807546C (en) 2010-08-10 2022-08-23 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2013033461A1 (en) 2011-08-31 2013-03-07 Rempex Pharmaceuticals, Inc. Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
UY34585A (es) * 2012-01-24 2013-09-02 Aicuris Gmbh & Co Kg Compuestos b-lactámicos sustituidos con amidina, su preparación y uso
US9156858B2 (en) 2012-05-23 2015-10-13 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US10561675B2 (en) 2012-06-06 2020-02-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
CN102757405B (zh) * 2012-07-25 2014-04-16 山东理工大学 含噻二唑的香兰素衍生物、其制备方法及其用途
MX2015008627A (es) 2013-01-04 2015-09-23 Rempex Pharmaceuticals Inc Derivados de acido boronico y usos terapeuticos de los mismos.
US9241947B2 (en) 2013-01-04 2016-01-26 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
KR20150103269A (ko) 2013-01-04 2015-09-09 렘펙스 파머수티클스 인코퍼레이티드 보론산 유도체 및 그의 치료적 용도
US9101638B2 (en) 2013-01-04 2015-08-11 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
ES2750805T3 (es) 2014-05-05 2020-03-27 Rempex Pharmaceuticals Inc Síntesis de sales de boronato y usos de las mismas
EP3139930B1 (en) 2014-05-05 2024-08-14 Melinta Therapeutics, Inc. Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
AU2015264418A1 (en) 2014-05-19 2016-11-10 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2016003929A1 (en) 2014-07-01 2016-01-07 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US10662205B2 (en) 2014-11-18 2020-05-26 Qpex Biopharma, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
EP3233869B1 (en) 2014-12-19 2019-09-25 Rempex Pharmaceuticals, Inc. Apparatus and continuous flow process for production of boronic acid derivatives
US20180051041A1 (en) 2015-03-17 2018-02-22 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
MX389349B (es) 2016-06-30 2025-03-20 Qpex Biopharma Inc Derivados de ácido borónico y usos terapéuticos de los mismos.
CN107641119B (zh) * 2016-07-21 2019-11-08 中国科学院上海药物研究所 单环β-内酰胺-铁载体轭合物及其制备方法和用途
US20200093814A1 (en) 2016-12-21 2020-03-26 Aicuris Gmbh & Co. Kg Combination therapy with amidine substituted beta-lactam compounds and beta-lactamase inhibitors for infections with antibiotic resistant bacterial strains
US11286270B2 (en) 2017-10-11 2022-03-29 Qpex Biopharma, Inc. Boronic acid derivatives and synthesis thereof
EP3747883A4 (en) 2018-01-29 2020-12-16 Medshine Discovery Inc. MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION
EP3781576B1 (en) 2018-04-20 2024-06-12 Qpex Biopharma, Inc. Boronic acid derivatives and therapeutic uses thereof
EP3901150B1 (en) 2018-12-18 2025-12-03 Shenzhen Optimum Biological Technology Co., Ltd Monocyclic beta-lactam compound for use in the treatment of pneumonia
SI25892A (sl) * 2019-09-05 2021-03-31 Gorenje Gospodinjski Aparati, D.O.O. Pralni stroj, ki se polni s sprednje strani, z električnim svetlobnim telesom
JP7630179B2 (ja) * 2019-09-11 2025-02-17 テンノア・セラピューティクス・（スージョウ）・リミテッド 細菌感染症を治療するためのペナム誘導体
CN114787158B (zh) 2019-11-22 2023-10-24 苏州二叶制药有限公司 磺酰脲环取代的单环β-内酰胺类抗生素
US12491180B2 (en) 2019-12-19 2025-12-09 Shenzhen Optimum Biological Technology Co., Ltd Application of compound in treating pneumonia
AU2021266715A1 (en) 2020-05-05 2022-11-17 Qpex Biopharma, Inc. Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof
CN113754651B (zh) * 2020-06-02 2023-04-18 中国医学科学院医药生物技术研究所 一种β-内酰胺化合物、其用途及其制备方法
CN117500802A (zh) 2021-03-31 2024-02-02 费多拉制药有限公司 Lactivicin化合物及其制备和作为抗菌剂的用途
US20250009891A1 (en) * 2021-08-20 2025-01-09 University Of Notre Dame Du Lac Conjugates of monocyclic beta-lactams and siderophore mimetics
CN115304594B (zh) 2022-10-12 2023-02-14 苏州二叶制药有限公司 磺酰脲环取代的化合物的盐型及其晶型

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4632985A (en) 1985-06-03 1986-12-30 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinesulfonic acids
GB8810396D0 (en) 1988-05-03 1988-06-08 Glaxo Group Ltd Chemical process
US5112968A (en) * 1989-07-28 1992-05-12 E. R. Squibb & Sons, Inc. Monobactam hydrazide derivatives
US5250691A (en) * 1991-09-09 1993-10-05 E. R. Squibb & Sons, Inc. Heteroaryl derivatives of monocyclic beta-lactam antibiotics
US5888998A (en) * 1997-04-24 1999-03-30 Synphar Laboratories, Inc. 2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors
US5994340A (en) * 1997-08-29 1999-11-30 Synphar Laboratories, Inc. Azetidinone derivatives as β-lactamase inhibitors

Also Published As

Publication number Publication date
DE60111757D1 (de) 2005-08-04
CN1458932A (zh) 2003-11-26
IL154593A (en) 2008-06-05
SK2462003A3 (en) 2003-09-11
HUP0301025A3 (en) 2009-03-30
CA2422375A1 (en) 2002-03-21
HUP0301025A2 (hu) 2004-04-28
CN1189469C (zh) 2005-02-16
KR100854810B1 (ko) 2008-08-27
DE60111757T2 (de) 2006-04-27
KR20030039369A (ko) 2003-05-17
WO2002022613A1 (en) 2002-03-21
CZ304586B6 (cs) 2014-07-23
ES2244666T3 (es) 2005-12-16
EP1322648B1 (en) 2005-06-29
PL360537A1 (en) 2004-09-06
AU1261402A (en) 2002-03-26
HK1054377A1 (en) 2003-11-28
PT1322648E (pt) 2005-11-30
NZ524292A (en) 2004-09-24
AU2002212614B2 (en) 2006-12-07
JP2004509122A (ja) 2004-03-25
EP1322648A1 (en) 2003-07-02
BR0113861A (pt) 2004-01-27
ATE298750T1 (de) 2005-07-15
DK1322648T3 (da) 2005-10-31
US20040019203A1 (en) 2004-01-29
NO324946B1 (no) 2008-01-07
ZA200302085B (en) 2004-03-15
US6916803B2 (en) 2005-07-12
CA2422375C (en) 2011-03-15
IL154593A0 (en) 2003-09-17
CZ2003606A3 (cs) 2003-08-13
PL218196B1 (pl) 2014-10-31
NO20031162L (no) 2003-03-13

Similar Documents

Publication Publication Date Title
DK1322648T3 (da) 3-(heteroarylacetamido)-2-oxo-azetidin-1-sulfonsyrederivater som antibakterielle midler
EA200501098A1 (ru) Антибактериальные агенты
EA200100623A1 (ru) Кетолидные антибиотики
CY1111693T1 (el) Αντιιικοι παραγοντες
EA200100396A1 (ru) Новые макролидные антибиотики
EA200100416A1 (ru) 13-членные азалиды и их применение в качестве антибиотических агентов
EA200400086A1 (ru) Новые производные оксазолидинонов в качестве антибактериальных агентов
ATE260928T1 (de) Ketolidantibiotika
EA200400530A1 (ru) Перекрестно-сшитые антибиотики "гликопептид-цефалоспорин"
NO20092655L (no) 2-kinolinon- og 2-kinoksalinonderivater og deres anvendelse som antibakterielle midler
EA200600374A1 (ru) Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью
ES2161344T3 (es) Derivados oxazolin-amidicos basicos de los antibioticos ge2270 y similares.
YU49796A (sh) Optički aktivni derivat fenil pirimidina
DE69600244D1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
EA200001029A1 (ru) Производные гигромицина
NO20010140L (no) Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse
PT1289998E (pt) Novo processo para a preparacao de derivados de vinil-pirrolidinona cefalosporina
PT1167376E (pt) Antibioticos macrolidos
DE60030300D1 (de) Topische behandlung zur vorbeugung von augeninfektionen
DE60117620D1 (de) Herstellung von cephalosporin
DE60326710D1 (de) Trizyklische antibakterielle makrolidderivate
EA200201167A1 (ru) Производные гигромицина а для лечения бактериальных и протозойных инфекций
EA200100768A1 (ru) Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees